Trial Profile
Study to evaluate the effect of liraglutide on anti-inflammatory activity in type 1 diabetes patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 28 Jul 2015 New trial record